Form 3 Aramark For: Jul 19 Filed by: Schilling Christopher T.

July 28, 2021 9:06 PM EDT

Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Expires: December 31, 2014
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person *
Schilling Christopher T.

(Last) (First) (Middle)
ARAMARK
2400 MARKET STREET

(Street)
PHILADELPHIA PA 19103

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
07/19/2021
3. Issuer Name and Ticker or Trading Symbol
Aramark [ ARMK ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
SVP, Controller and CAO
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 10,463.895 (1)
D
 
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy)   (2) 11/16/2027 Common Stock 6,943 40.74 D  
Stock Option (Right to Buy)   (3) 09/04/2030 Common Stock 7,551 28.3 D  
Stock Option (Right to Buy)   (4) 11/21/2029 Common Stock 4,268 42.43 D  
Stock Option (Right to Buy)   (5) 06/01/2031 Common Stock 15,256 37.23 D  
Stock Option (Right to Buy)   (6) 11/15/2028 Common Stock 4,845 36.74 D  
Explanation of Responses:
1. Includes 5,373 restricted stock units which will vest in three annual installments on June 1, 2022, 2023, and 2024; 2,406.47 restricted stock units which will vest in three annual installments on September 4, 2021, 2022, and 2023; 488.884 restricted stock units which will vest in three annual installments on November 21, 2021, 2022, and 2023; 381.065 restricted stock units which will vest in two annual installments on November 15, 2021 and 2022; and 262.945 restricted stock units which will vest on November 16, 2021.
2. Represents stock options, 5,205 of which have fully vested and 1,738 which will vest on November 16, 2021.
3. Represents stock options, 2,517 which will vest on September 4, 2021, 2,517 which will vest on September 4, 2022, and 2,517 which will vest on September 4, 2023.
4. Represents stock options, 1,067 of which have fully vested and 1,067 which will vest on November 21, 2021, 1,067 which will vest on November 21, 2022, and 1,067 which will vest on November 21, 2023.
5. Represents stock options, 5,085 which will vest on June 1, 2022, 5,085 which will vest on June 1, 2023, and 5,086 which will vest on June 1, 2024.
6. Represents stock options, 2,422 of which have fully vested and 1,211 which will vest on November 15, 2021 and 1,212 which will vest on November 15, 2022.
Remarks:
Exhibit List: Exhibit 24 - Power of Attorney
/s/ Harold B. Dichter, as Attorney-in-fact 07/28/2021
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Christopher T. Schilling

POWER OF ATTORNEY


The undersigned hereby constitutes and appoints each of Harold B. Dichter, Paige E. Fleming, and Andrew L. Unton his true and lawful attorney-in-fact to:

(1) execute for and on behalf of the undersigned, in the undersigned’s capacity as a director or executive officer of Aramark (the “Company”), as applicable, (i) Forms 3, 4 or 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934, as amended, and the rules thereunder (including any amendments thereto) and (ii) such forms as may be required in connection with any applications for EDGAR access codes, including without limitation the Form ID.

(2) do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete the execution of any such Form 3, 4, or 5 and the timely filing of such form with the United States Securities and Exchange Commission and any other authority; and

(3) take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in his discretion.

The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform every act and thing whatsoever requisite, necessary and proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact’s substitute or substitutes, shall lawfully do or cause to be done by virtue of this Power of Attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming any of the undersigned’s responsibilities to comply with Section 16 of the Securities Exchange Act of 1934, as amended.

This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4 and 5 with respect to the undersigned’s holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact.





IN WITNESS WHEREOF, the undersigned has executed this Power of Attorney on the 21st day of July, 2021.


/s/ Christopher T. Schilling
Signature
Christopher T. Schilling
Printed Name




Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings